Business

Uxin Limited (NASDAQ: UXIN) Investor Lawsuit alleges False and Misleading Statements

Press Release

An investor, who purchased shares of Uxin Limited (NASDAQ: UXIN), filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Uxin Limited in connection with certain allegedly false and misleading statements made in connection with Uxin’s initial public offering (“IPO”) held on or around June 27, 2018.

Investors who purchased shares of Uxin Limited (NASDAQ: UXIN) have certain options and for certain investors are short and strict deadlines running. Deadline: April 12, 2019. NASDAQ: UXIN investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.

According to the complaint the plaintiff alleges that the Registration Statement was materially false and misleading and omitted to state that the company was likely to stop providing complementary services such as inspections to its customers, that instead, the company would connect consumers to dealers who would provide such complementary services, that as a result, the company’s 2B business would be materially impacted, and that as a result of the foregoing, defendants’ statements in the Registration Statement regarding Uxin’s business, operations, and prospects, were materially false and/or misleading.

According to the complaint the plaintiff alleges on behalf of purchasers of the securities of Uxin Limited (NASDAQ: UXIN) pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with Uxin’s initial public offering (“IPO”) held on or around June 27, 2018, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that the Registration Statement was false and/or misleading and/or failed to disclose that Uxin Limited was likely to stop providing complementary services such as inspections to its customers, that instead, Uxin would connect consumers to dealers who would provide such complementary services, that as a result, Uxin’s 2B business would be materially impacted, and that consequently, defendants’ statements in the Registration Statement concerning Uxin’s business, operations, and prospects, were materially false and/or misleading.

Those who purchased shares of Uxin Limited (NASDAQ: UXIN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
[email protected]

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

RSS news